- Home
- FIVE vs ELAN Comparison
FIVE vs ELAN Comparison
Compare FIVE & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIVE
- ELAN
- Stock Information
- Founded
- FIVE 2002
- ELAN 1954
- Country
- FIVE United States
- ELAN United States
- Employees
- FIVE N/A
- ELAN N/A
- Industry
- FIVE Department/Specialty Retail Stores
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- FIVE Consumer Discretionary
- ELAN Health Care
- Exchange
- FIVE Nasdaq
- ELAN Nasdaq
- Market Cap
- FIVE 6.7B
- ELAN 6.6B
- IPO Year
- FIVE 2012
- ELAN 2018
- Fundamental
- Price
- FIVE $131.09
- ELAN $14.29
- Analyst Decision
- FIVE Buy
- ELAN Buy
- Analyst Count
- FIVE 19
- ELAN 7
- Target Price
- FIVE $115.94
- ELAN $15.17
- AVG Volume (30 Days)
- FIVE 1.7M
- ELAN 5.3M
- Earning Date
- FIVE 06-04-2025
- ELAN 08-07-2025
- Dividend Yield
- FIVE N/A
- ELAN N/A
- EPS Growth
- FIVE N/A
- ELAN N/A
- EPS
- FIVE 4.78
- ELAN 0.75
- Revenue
- FIVE $4,035,191,000.00
- ELAN $4,427,000,000.00
- Revenue This Year
- FIVE $16.13
- ELAN $4.28
- Revenue Next Year
- FIVE $9.97
- ELAN $4.67
- P/E Ratio
- FIVE $27.32
- ELAN $19.07
- Revenue Growth
- FIVE 10.71
- ELAN 1.42
- 52 Week Low
- FIVE $52.38
- ELAN $8.02
- 52 Week High
- FIVE $137.30
- ELAN $15.78
- Technical
- Relative Strength Index (RSI)
- FIVE 66.87
- ELAN 66.32
- Support Level
- FIVE $121.11
- ELAN $13.16
- Resistance Level
- FIVE $133.33
- ELAN $14.15
- Average True Range (ATR)
- FIVE 3.69
- ELAN 0.39
- MACD
- FIVE -0.79
- ELAN -0.05
- Stochastic Oscillator
- FIVE 65.38
- ELAN 83.70
About FIVE Five Below Inc.
Five Below Inc is a specialty value retailer offering merchandise targeted at the tween and teen demographic. The Company's edited assortment of products includes select brands and licensed merchandise. It derives revenue from sales of the Company's merchandise to customers.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.